Association between atherogenic index of plasma and all-cause mortality and cardiovascular disease among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease
This study showed that AIP is an effective tool for predicting CVD risk and mortality in patients with NAFLD and MASLD. Regular monitoring of AIP levels can help identify high-risk patients early and provide clinical risk assessment before intervention, thereby improving patient management and prognosis. Future studies need to further explore the role of AIP in different ethnic and economic conditions to optimize cardiovascular disease prevention and treatment strategies.
Authors
- Jiaxin Shao (ORCID: https://orcid.org/0000-0001-9998-3622)
- Pan Huang (ORCID: https://orcid.org/0000-0003-0098-8517)
- Jian Teng (ORCID: https://orcid.org/0000-0002-5142-3893)
- Jian Jin (ORCID: https://orcid.org/0000-0002-1034-5710)
- Xizi Jiang (ORCID: https://orcid.org/0000-0002-8676-4153)
- J. Lv (ORCID: https://orcid.org/0000-0002-8606-3656)
- Jianghua Zhou
- Jiangnan Yao
- Fuman Cai (ORCID: https://orcid.org/0000-0002-9271-5032)
- Qianrong Zheng
- Leyi Zheng
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1186/s13098-025-01715-7
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Wenzhou Municipal Science and Technology Bureau